Arrowhead (ARWR) is down -11.5%, or -$1.92 to $14.84.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Arrowhead falls -8.9%
- Cautious Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Sarepta Partnership
- Arrowhead Pharmaceuticals Advances Phase 3 Study of Zodasiran for Cholesterol Management
- Arrowhead Pharmaceuticals Advances Phase 3 Study on Plozasiran for Hypertriglyceridemia
- Arrowhead doses first patient in YOSEMITE trial